T1	Participants 59 104	subjects with a history of insulin resistance
T2	Participants 105 128	and colorectal adenomas
T3	Participants 538 594	subjects with four possible combinations of risk factors
T4	Participants 726 768	participant (a total of 23; 5-12 per group
